Skip to main content
SpringerLink
Log in

Prevention of Cancer with Pomegranate and Pomegranate Anthocyanins

  • Chapter
  • First Online:
Berries and Cancer Prevention

Abstract

The fruit of the pomegranate tree (Punica granatum L.) has recently attracted attention based on anecdotal evidence and studies suggesting that it possesses antioxidant, anti-inflammatory and anti-cancer properties. The pomegranate (literally translated as seeded apple) plant is a shrub that commonly grows 6–15 ft tall. The fruit is a berry (globose) that is 2–3 inches in diameter and reddish when fully mature. It is filled with crunchy and juicy seeds that are eaten and used for extracting the juice. However, industrial preparations use the whole fruit for juice extraction. Antioxidant activity of flavonoids extracted from pomegranate fermented juice showed strong activity close to that of green tea and significantly higher than that of red wine. Preclinical laboratory studies have suggested that pomegranate and its constituents possess cancer preventive properties against skin, prostate, breast, colon, and lung cancers. Epidemiological, clinical, and case-control studies have not been conducted for pomegranate; however, a phase II clinical trial was recently conducted in patients with rising prostate specific antigen (PSA), a clinical marker for prostate cancer. Pomegranate juice given to men with rising PSA following surgery or radiation offered positive and beneficially significant effects on PSA parameters, suggesting a potential of pomegranate derived products for prevention of human prostate cancer. This chapter will focus on the laboratory and some clinical evidence on the cancer preventive properties of the pomegranate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54:980–985

    Article  CAS  PubMed  Google Scholar 

  • Adams LS, Zhang Y, Seeram NP, Heber D, Chen S (2010) Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res 3:108–113

    Article  CAS  Google Scholar 

  • Adhami VM, Khan N, Mukhtar H (2009) Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer 61:811–815

    Article  PubMed  Google Scholar 

  • Adhami VM, Mukhtar H (2007) Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol 37:52–57

    Article  CAS  PubMed  Google Scholar 

  • Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H (2005b) Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 81:38–45

    Article  CAS  PubMed  Google Scholar 

  • Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H (2005a) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113:423–433

    Article  CAS  PubMed  Google Scholar 

  • Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H (2009) Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp Dermatol 18:553–561

    Article  CAS  PubMed  Google Scholar 

  • Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM (2004) Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food 7:274–283

    Article  CAS  PubMed  Google Scholar 

  • Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062–1076

    CAS  PubMed  Google Scholar 

  • 1Ben Nasr C, Ayed N, Metche M (1996) Quantitative determination of the polyphenolic content of pomegranate peel. Z Lebensm Unters Forsch 203:374–378

    Article  CAS  PubMed  Google Scholar 

  • Bin Hafeez B, Asim M, Siddiqui IA, Adhami VM, Murtaza I, Mukhtar H (2008) Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth. Cell Cycle 7:3320–3326

    Article  CAS  PubMed  Google Scholar 

  • Boateng J, Verghese M, Shackelford L, Walker LT, Khatiwada J, Ogutu S, Williams DS, Jones J, Guyton M, Asiamah D, Henderson F, Grant L, DeBruce M, Johnson A, Washington S, Chawan CB (2007) Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem Toxicol 45:725–732

    Article  CAS  PubMed  Google Scholar 

  • Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA (2004) The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43:205–220

    Article  PubMed  Google Scholar 

  • Elswijk DA, Schobel UP, Lansky EP, Irth H, van der Greef J (2004) Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 65:233–241

    Article  PubMed  Google Scholar 

  • Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48:4581–4589

    Article  CAS  PubMed  Google Scholar 

  • Grossmann ME, Mizuno NK, Schuster T, Cleary MP (2010) Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int J Oncol 36:421–426

    CAS  PubMed  Google Scholar 

  • Hafeez BB, Siddiqui IA, Asim M, Malik A, Afaq F, Adhami VM, Saleem M, Din M, Mukhtar H (2008) A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res 68:8564–8572

    Article  PubMed  Google Scholar 

  • Hong MY, Seeram NP, Heber D (2008) Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutriochem 19:848–855

    CAS  Google Scholar 

  • Hora JJ, Maydew ER, Lansky EP, Dwivedi C (2003) Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J Med Food 6:157–161

    Article  CAS  PubMed  Google Scholar 

  • Jeune MA, Kumi-Diaka J, Brown J (2005) Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 8:469–475

    Article  CAS  PubMed  Google Scholar 

  • Jurenka JS (2008) Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev 13:128–144

    PubMed  Google Scholar 

  • Kasimsetty SG, Bialonska D, Reddy MK, Thornton C, Willett KL, Ferreira D (2009) Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J Agric Food Chem 57:10636–10644

    Article  CAS  PubMed  Google Scholar 

  • Kawaii S, Lansky EP (2004) Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Med Food 7:13–18

    Article  CAS  PubMed  Google Scholar 

  • Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD (2009) Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther 8:242–253

    Article  CAS  PubMed  Google Scholar 

  • Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H (2007b) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 67:3475–3482

    Article  CAS  PubMed  Google Scholar 

  • Khan N, Afaq F, Mukhtar H: (2008) Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10:475–510

    Article  CAS  PubMed  Google Scholar 

  • Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H (2007a) Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28:163–173

    Article  CAS  PubMed  Google Scholar 

  • Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E (2002) Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71:203–217

    Article  CAS  PubMed  Google Scholar 

  • Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T (2004) Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 95:481–486

    Article  CAS  PubMed  Google Scholar 

  • Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D, Pantuck AJ, Cohen P (2010) Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res 20:55–62

    Article  CAS  PubMed  Google Scholar 

  • Kuiper JMGG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JÄ (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252–4263

    Article  CAS  PubMed  Google Scholar 

  • Langley P (2000) Why a pomegranate? BMJ 321:1153–1154

    Article  CAS  PubMed  Google Scholar 

  • Lansky EP, Harrison G, Froom P, Jiang WG (2005b) Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 23:121–122

    Article  CAS  PubMed  Google Scholar 

  • Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, Harris NM, Neeman I, Campbell MJ (2005a) Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs 23:11–20

    Article  CAS  PubMed  Google Scholar 

  • Lansky EP (2006) Beware of pomegranates bearing 40% ellagic Acid. J Med Food 9:119–122

    Article  CAS  PubMed  Google Scholar 

  • Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2006a) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54:1611–1620

    Article  CAS  PubMed  Google Scholar 

  • Larrosa M, Tomás-Barberán FA, Espín JC (2006b) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutriochem 17:611–625

    CAS  Google Scholar 

  • Longtin R (2003) The pomegranate: nature’s power fruit? J Natl Cancer Inst 95:346–348

    Article  PubMed  Google Scholar 

  • Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102:14813–14818

    Article  CAS  PubMed  Google Scholar 

  • Malik A, Mukhtar H (2006) Prostate cancer prevention through pomegranate fruit. Cell Cycle 5:371–373

    Article  CAS  PubMed  Google Scholar 

  • Mehta R, Lansky EP (2004) Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev 13:345–348

    Article  CAS  PubMed  Google Scholar 

  • Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS (2005) Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135:609–614

    CAS  PubMed  Google Scholar 

  • Mertens-Talcott SU, Percival SS (2005) Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218:141–151

    Article  CAS  PubMed  Google Scholar 

  • Noda Y, Kaneyuki T, Mori A, Packer L (2002) Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem 50:166–171

    Article  CAS  PubMed  Google Scholar 

  • Pacheco-Palencia LA, Noratto G, Hingorani L, Talcott ST, Mertens-Talcott SU (2008) Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J Agric Food Chem 56:8434–8441

    Article  CAS  PubMed  Google Scholar 

  • Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A (2006) PhaseII study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026

    Article  CAS  PubMed  Google Scholar 

  • Reed JD, Krueger CG, Vestling MM (2005) MALDI-TOF mass spectrometry of oligomeric food polyphenols. Phytochemistry 66:2248–2263

    Article  CAS  PubMed  Google Scholar 

  • Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A (2008) Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Cancer Ther 7:2662–2671

    Article  CAS  PubMed  Google Scholar 

  • Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D (2008) Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol 32:475–480

    CAS  PubMed  Google Scholar 

  • Saruwatari A, Okamura S, Nakajima Y, Narukawa Y, Takeda T, Tamura H (2008) Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J Med Food 11:623–628

    Article  CAS  PubMed  Google Scholar 

  • Schubert SY, Lansky EP, Neeman I (1999) Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 66:11–17

    Article  CAS  PubMed  Google Scholar 

  • Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutriochem 16:360–367

    CAS  Google Scholar 

  • Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A, Heber D (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55:7732–7737

    Article  CAS  PubMed  Google Scholar 

  • Sharma M, Li L, Celver J, Killian C, Kovoor A, Seeram NP (2010) Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J Agric Food Chem 58:3965–3969

    Article  CAS  PubMed  Google Scholar 

  • Sturgeon SR, Ronnenberg AG (2010) Pomegranate and breast cancer: possible mechanisms of prevention. Nutr Rev 68:122–128

    Article  PubMed  Google Scholar 

  • Syed DN, Malik A, Hadi N, Sarfaraz S, Afaq F, Mukhtar H (2006) Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochem Photobiol 82:398–405

    Article  CAS  PubMed  Google Scholar 

  • Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A (2003) Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 6:121–128

    Article  CAS  PubMed  Google Scholar 

  • Tran HN, Bae SY, Song BH, Lee BH, Bae YS, Kim YH, Lansky EP, Newman RA (2010) Pomegranate (Punica granatum) seed linolenic acid isomers: concentration-dependent modulation of estrogen receptor activity. Endocr Res 35:1–16

    Article  CAS  PubMed  Google Scholar 

  • Zaid MA, Afaq F, Syed DN, Dreher M, Mukhtar H (2007) Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx. Photochem Photobiol 83:882–888

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The original work from the author’s (H.M.) laboratory outlined in this chapter was supported by United States Public Health Service Grants R01 CA 78809 and RO1 CA 120451.

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Wisconsin, Madison, WI, 53706, USA

    Vaqar Mustafa Adhami, Naghma Khan & Hasan Mukhtar

Authors
  1. Vaqar Mustafa Adhami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naghma Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hasan Mukhtar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hasan Mukhtar .

Editor information

Editors and Affiliations

  1. Lower College Road 41, Kingston, 02881, Rhode Island, USA

    Navindra P. Seeram

  2. TBRC, Rm C4815, Department of Medicine, Medical College of Wisconsin, Watertown Plank Road 8701, Milwaukee, 53226, Ohio, USA

    Gary D. Stoner

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer New York

About this chapter

Cite this chapter

Adhami, V.M., Khan, N., Mukhtar, H. (2011). Prevention of Cancer with Pomegranate and Pomegranate Anthocyanins. In: Seeram, N., Stoner, G. (eds) Berries and Cancer Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7554-6_11

Download citation

Publish with us

Policies and ethics

Search

Navigation